CC
JNJ icon

Climber Capital’s Johnson & Johnson JNJ Stock Holding History

Climber Capital’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$232K Sell
915
-558
-38% -$130K 0.14% 61
2026
Q1 		$360K Sell
1,473
-565
-28% -$132K 0.24% 61
2025
Q4 		$421K Buy
+2,038
New +$403K 0.27% 46
2025
Q2 		$368K Buy
2,420
+214
+10% +$32.9K 0.24% 51
2025
Q1 		$300K Buy
2,206
+111
+5% +$17.4K 0.24% 49
2024
Q4 		$303K Buy
+2,095
New +$325K 0.25% 45

Other funds holding JNJ

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
AACR
ACR Alpine Capital Research St. Louis, Missouri $7.04B AUM 28% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Climber Capital's JNJ Position: Q2 2026 in Review

Climber Capital reduced its Johnson & Johnson (JNJ) stake by 38% in Q2 2026, selling an estimated $130K and leaving 915 shares worth $232K. The position accounts for 0.14% of the portfolio, ranked #61.

Climber Capital first reported a position in JNJ in Q4 2024 and has held it in 6 quarters since. The position peaked at $421K in Q4 2025. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Climber Capital held 915 shares of Johnson & Johnson worth $232K as of Q2 2026.
  • Climber Capital sold 558 Johnson & Johnson shares in Q2 2026, an estimated $130K.
  • Johnson & Johnson made up 0.14% of Climber Capital's portfolio in Q2 2026, its #61 holding.
  • Climber Capital first reported a position in Johnson & Johnson in Q4 2024 and has held it in 6 quarters since.
  • Climber Capital's Johnson & Johnson position peaked at $421K in Q4 2025.
  • 2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Climber Capital's 13F filing for Q2 2026, filed 22 Jul 2026.